Calidi Biotherapeutics Inc (CLDI)
0.2457
0.00 (0.00%)
USD |
NYAM |
May 21, 10:03
Calidi Biotherapeutics Total Liabilities (Quarterly): 21.98M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 21.98M |
December 31, 2023 | 18.25M |
September 30, 2023 | 19.68M |
June 30, 2023 | 73.89M |
Date | Value |
---|---|
December 31, 2022 | 53.04M |
September 30, 2022 | 45.54M |
December 31, 2021 | 35.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
18.25M
Minimum
Dec 2023
73.89M
Maximum
Jun 2023
38.20M
Average
35.00M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
Minerva Neurosciences Inc | 87.10M |
Viking Therapeutics Inc | 33.63M |
CytomX Therapeutics Inc | 216.37M |
Genprex Inc | 3.808M |
Janux Therapeutics Inc | 33.22M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 7.405M |
Shareholders Equity (Quarterly) | -14.57M |